introduction empyema generally defined pathological condition accumulates thoracic cavity empyema associated pneumonia chest surgery trauma esophageal perforation usa people hospitalized pneumonia year –40 pleural effusion –10 pleural effusion develop empyema japan pleural effusion occurs –40 people bacterial pneumonia 0.5 people pleural effusion develop empyema local treatment drainage useful antibacterial agent administered usually reach low concentration thoracic cavity however effect intrathoracic irrigation well investigated one reason normal saline safe liquid available intrathoracic irrigation report human clinical study show povidone-iodine effective empyema pleural infection moreover pleurodesis using povidone-iodine air leak following lung surgery malignant pleural effusion chylothorax successful occurrence non-serious adverse event chest pain however japan currently approved use body cavity concern tissue damage residue additionally chlorhexidine approved skin sanitizer japan focused using ozone dissolved water clean thoracic cavity ozone dissolved water well-known bactericidal effect effect various microorganism reported ozone dissolved water safely used sterilize surface food vegetable fruit however ozone dissolved water high deactivation rate half-life 20–30 min ozone solution need prepared immediately clinical use ozone dissolved water readily deactivated organic matter technique preparing liquid containing bubble diameter 100–200 called ultrafine bubble ufbs recently developed ozone ufbs remain dissolved stable longer non-ufb ozone solution containing ozone-ufbs used medical field several publication efficacy safety using ozone-ufbs treat periodontal disease however study efficacy safety using ozone-ufbs within body cavity performed furthermore effect solution containing ozone-ufb presence organic matter unclear assessed bactericidal effect solution containing ozone-ufbs presence organic matter vitro bactericidal effect solution containing ozone-ufbs rat empyema model effect solution containing ozone-ufbs injected thoracic cavity rat tissue damage material method preparing solution containing ozone-ufbs determining ozone concentration ozone-ufb solution prepared using two-step procedure first oxygen separated air ozone created oxygen using silent electric discharge system pzh-12n ozone production device kofloc kyoto japan second ozone-ufbs created normal saline solution otsuka pharmaceutical tokyo japan dissolving ozone applying power causing cavitations form using ufb creation device living energy co. shizuoka japan ufb particle per milliliter solution ufb diameter 100–200 number ufbs remained sufficient test day number ufbs determined using nanosight system malvern panalytical malvern ufb size distribution shown supplemental fig dissolved ozone concentration ozone-ufb decreased slowly dissolved ozone concentration containing non-ufb ozone room temperature shown supplemental fig supersaturated ozone rapidly volatilized first min ozone-ufb produced ozone concentration decreased slowly remained mg/l contrast almost ozone detected containing non-ufb ozone another min time achieve disinfection microorganism several microorganism cause empyema staphylococcus aureus atcc aureus atcc pseudomonas aeruginosa atcc aeruginosa atcc used study obtained american type culture collection atcc methicillin-resistant aureus mrsa obtained clinical sample kyoto university hospital mrsa -kyoto peptostreptococcus anaerobius gtc anaerobius gtc obtained gifu university center conservation microbial genetic resourcethrough national bioresource project pathogenic bacteria run mext/amed japan aureus atcc aeruginosa atcc mrsa -kyoto grown trypticase soy agar franklin lake usa day anaerobius gtc grown anaerobically gam agar nissui pharmaceutical tokyo japan day sample preparation 0.1 aliquot culture medium containing colony forming unit cfus test bacteria added 0.9 ozone-ufb one several concentration prepared solution initial ozone concentration 0.4 mg/l bactericidal effect ozone-ufb compared bactericidal effect 0.5 chlorhexidine gluconate chx 0.5 hexizac water yoshida pharmaceutical saitama japan mixture incubated min test compare bactericidal effect ozone-ufb chx bacterial suspension incubated either min duration bactericidal effect solution different chx become deactivated mixed solution ozone-ufb rapidly became deactivated bactericidal effect ozone-ufb anaerobius gtc air-ufb also compared counting bacterial colony exposure test solution incubation 0.1 aliquot mixture aseptically transferred petri dish mixed trypticase soy agar medium mixture incubated day aureus atcc aeruginosa atcc mrsa -kyoto mixed gam agar medium incubated day anaerobic condition anaerobius gtc test performed compare ozone-ufb chx solution 0.1 aliquot mixture aseptically transferred petri dish mixed tryptic soy agar containing polysorbate lecithin nissui pharmaceutical deactivate test solution mixture incubated day colony formed counted minimum bactericidal concentration mbc calculated mbcs aureus atcc aeruginosa atcc non-ufb ozone solution ozone-ufb solution compared bactericidal effect ozone-ufb solution solution containing bacteria albumin dissolved ozone readily deactivated organic matter assessed bactericidal effect ozone-ufb solution solution containing aureus atcc albumin vitro test imitating intrathoracic environment empyema bactericidal effect ozone-ufb solution different albumin concentration aliquot culture medium containing cfus/ml aureus atcc mixed containing bovine albumin serologicals corporation norcross usa concentration 0.1 0.1 aliquot mixture added 0.9 ozone-ufb solution ozone concentration 0.5 mg/l mixture incubated min 0.1 aliquot mixture aseptically transferred petri dish mixed trypticase soy agar medium mixture incubated day colony counted bactericidal effect ozone-ufb solution added several time solution containing aureus albumin aliquot culture medium containing cfus/ml aureus atcc mixed containing bovine albumin concentration 0.1 aliquot mixture added 0.9 ozone-ufb solution ozone concentration 0.7–1.0 mg/l 0.1 aliquot mixture transferred tube containing 0.9 ozone-ufb solution dilution repeated two time mixture 0.1 aliquot aseptically transferred petri dish mixed trypticase soy agar medium mixture incubated day colony counted rat empyema model preparation controlled experiment performed institute laboratory animal graduate school medicine kyoto university kyoto japan study protocol procedure approved kyoto university ethic committee approval number med kyo animal received humane care compliance principle laboratory animal care outlined federal resolution 04/97 study carried compliance arrive guideline male lewis rat weighing 280–330 randomly selected rat supplier japan slc hamamatsu japan effect intrathoracic lavage using ozone-ufbs compared effect lavage using using rat empyema model using aureus atcc one common cause empyema rat empyema model created performing intrathoracic injection 1.0 containing bacteria cfus aureus atcc bacteria solution injected right thoracic cavity diaphragm performing small laparotomy avoid postoperative adhesion procedure performed using aseptic technique treatment assessment two day aureus atcc injected rat sufficient pleural purulent effusion 0.5 aureus atcc detected culturing liquid defined empyema survival expected empyema model rat sacrificed causing inhale lethal dose isoflurane rat placed lateral decubitus position skin disinfection performed ethanol followed povidone-iodine following procedure conducted aseptic manner using sterilized material right thoracotomy resection several rib performed allow entire thoracic space inspected pleural effusion occurred side thoracic space mediastinal pleura removed allow pleural effusion collected side effusion collected lavage performed twice time using urokinase mochida pharmaceutical tokyo japan diluted give units/ml min remove suspended organic matter thoracic cavity filled min ozone-ufb repeated time ozone-ufb ozone concentration 3–4 mg/l used lavage procedure lavage performed time thoracic cavity rat group filled min liquid first fifth 10th last lavage cultured pleural effusion urokinase lavage liquid diluted factor immersion liquid diluted factor 0.1 aliquot sample aseptically transferred petri dish mixed trypticase soy agar medium mixture incubated day colony counted decrease number aureus atcc first fifth 10th last immersion liquid determined compared total bacterial count initial pleural effusion urokinase lavage liquid vivo toxicity study laparotomy performed manner empyema model using male lewis rat weighing 280–330 1.0 aliquot containing ozone-ufbs ozone concentration 9–10 mg/l 1.0 aliquot control injected intrathoracically diaphragm incision closed without collecting injected liquid toxicity evaluated later rat sacrificed liquid injected blood sample obtained inferior vena cava rat interleukin-6 il-6 concentration serum sample determined used indicate inflammation il-6 concentration determined performing enzyme-linked immune sorbent assay using legend max™ rat il-6 elisa kit biolegend san diego usa lower right lung lobe heart liver right kidney resected histopathological examination allow inflammatory change evaluated tissue sample fixed formalin stained hematoxylin–eosin rat weighed intervention later statistical analysis result presented median interquartile range unless otherwise stated result pair group compared performing fisher exact test categorical data mann–whitney test nonparametric variable wilcoxon signed rank test used compare mbcs aureus atcc aeruginosa atcc non-ufb ozone ozone-ufb solution 0.05 considered indicate statistically significant result statistical analysis performed using ezr statistical software saitama medical center jichi medical university saitama japan result time achieve disinfection enumeration bacterial colony following exposure solution median mbcs aureus atcc aeruginosa atcc ozone-ufb min 1/8 range 1/4 1/16 mbcs aureus atcc aeruginosa atcc non-ufb ozone ozone-ufb relative mbc distribution table shown fig mbcs aureus atcc aeruginosa atcc lower ozone-ufb non-ufb ozone 0.034 aureus atcc 0.036 aeruginosa atcc figure minimum bactericidal concentration staphylococcus aureus atcc pseudomonas aeruginosa atcc normal saline solution containing ozone ultrafine bubble ozone ozone-ufb relative minimum bactericidal concentration distribution table full size image median mbc dilution rate solution containing ozone concentration 0.4 mg/l mrsa -kyoto min 1/4 range 1/2 1/4 median mbc mrsa -kyoto min 1/24 range 1/4 1/32 median mbc effective ozone concentration anaerobius gtc 1.6 cfu/ml min 1.1 mg/l without dilution air-ufb bactericidal effect median mbcs aureus atcc min 1/4 range 1/4 1/4 ozone-ufb chx median mbcs aureus atcc min 1/8 ozone-ufb 1/16 chx bactericidal effect ozone-ufb solution different albumin concentration ozone-ufb bactericidal effect aureus atcc solution containing albumin concentration g/dl fig figure bactericidal effect ultrafine bubble ozone normal saline solution solution staphylococcus aureus atcc albumin ultrafine bubble ozone bactericidal effect bacteria solution containing albumin concentration g/dl bsa bovine serum albumin full size image bactericidal effect ozone-ufb solution added several time solution containing aureus albumin irrigating aureus atcc solution containing albumin three time ozone-ufb completely sterilized solution irrigating diluted aureus atcc fig figure bactericidal effect repeated treatment ultrafine bubble ozone ozone-ufb normal saline solution containing albumin staphylococcus aureus atcc ozone-ufb bactericidal effect three treatment full size image rat empyema model solution aureus atcc 1.6 –3.5 cfu/ml injected rat four rat died treatment two rat effusion eight rat insufficient pleural effusion 0.5 result rat therefore evaluated rat divided two group treatment treatment ozone-ufb appearance thoracic cavity day injection aureus atcc shown fig purulent effusion fibrin observed right left thoracic cavity volume pleural effusion comparable ozone-ufb group 1.3 range 1.1–1.6 vs. 1.2 range 1.1–1.5 0.588 thoracic lavage therefore performed side thoracic cavity left thoracic cavity figure empyema treatment sacrificed rat model staphylococcus aureus atcc injected right thoracic cavity via diaphragm laparotomy two day later purulent effusion fibrin observed right left part thoracic cavity full size image decrease bacteria count lavage shown fig aureus atcc count pleural effusion fluid collected urokinase lavage decreased 11.8 range 4.5 –21.1 4.6 range 3.2 –13.6 respectively 0.417 first lavage 4.2 range 2.3 –9.0 0.6 range 0.6 –1.3 respectively 0.007 fifth lavage 6.7 range 3.4 –20.6 0.3 range 0.2 –0.9 respectively 0.019 10th lavage 7.5 range 2.4 –11.7 0.5 range 0.2 –1.6 respectively 0.007 last lavage figure decrease bacteria count lavage empyema staphylococcus aureus atcc compared bacteria count initial effusion decrease larger rat treated ultrafine bubble ozone ozone-ufb rat treated normal saline solution five lavage iqr interquartile range full size image vivo toxicity study rat used toxicity study three excluded technical damage remaining rat divided two group nss-treated rat rat treated ozone-ufbs 9–10 mg/l rat survived evaluation period weight treatment relative weight treatment 99.0 range 98.2 –99.1 group 96.0 range 91.1 –98.1 ozone-ufb group 0.138 serum il-6 concentration rat 5.3 pg/ml pathological examination indicated proliferation type alveolar epithelial cell around airway occurred one rat group focal proliferation type alveolar epithelial cell without infiltration inflammatory cell occurred one rat ozone-ufb group aspiration pneumonia occurred one rat ozone-ufb group inflammatory change e.g. pleuritis chemical pneumonitis hepatitis nephritis detected rat fig figure pathological examination rat organ injection ultrafine bubble ozone ozone-ufb normal saline solution right part thoracic cavity hematoxylin eosin stain significant inflammatory change right lower lung heart liver kidney either rat treated ozone-ufbs full size image discussion ozone discovered christian friedrich schonbein use medicine reported early 1900s ozone powerful oxidizing substance bactericidal cytotoxic effect bioavailability ozone considered useful long capacity exceeded ozone high sterilization ability low persistence therefore also used sterilization wastewater food material ozone antimicrobial effect various bacteria fungi well virus coronavirus medical field ozonated water applied dental treatment however protective ability ozone respiratory epithelium low inhalation ozone gas 0.1 ppm must avoided handling ozone method dissolving ozone liquid rather gaseous state investigated strategy limited ozone short half-life becomes unstable liquid developed ozone-ufb solution long half-life found excellent bactericidal effect safe vitro vivo test effect ozone non-ufb solution decrease immediately half-life short readily deactivated organic-matter-rich environment using ozone solution non-ufb sterilization purpose choice use high concentration diluted ozone far therefore ozone solution safely used antibacterial treatment thoracic cavity possibility ozone harmful although lavage drainage tube using ozonated water high ozone concentration mg/l urokinase human performed one previous study found sufficient bactericidal effect achieved sacrificed rat model repeated lavage using ozone-ufb solution 3–4 mg/l even ozone concentration lower ozone concentration non-ufb ozone solution used previous study addition existing treatment antibiotic therapy drainage intrathoracic lavage useful promote clearance thoracic cavity observed performing intrathoracic lavage five time result proportional decrease rate reduction bacteria facilitate bactericidal effect ozone-ufb solution would possible lower concentration organic matter using fibrinolytic therapy urokinase also considering way improve bactericidal effect ozone-ufb intrathoracic lavage using ozone higher concentration within safety range intraoperative postoperative use surgical treatment assessed safety injecting ozone-ufb solution chest cavity rat ozone concentration 9–10 mg/l acceptable pathological exam result il-6 concentration previous vitro model study dental field found cell viability oral tissue exposed ozone nanobubbles water slightly decreased contrast cell viability oral tissue exposed 0.2 chx halved 8.4 suggesting chx damage human oral tissue ozone nanobubbles water would safer oral antiseptic evaluation safety application ozone-ufbs therapy human essential several report regarding ozone nanobubble water therapy periodontitis low toxicity ozone nanobubble water gingival tissue reported addition shichiri-negoro reported ozonated water diluted ozone concentration ppm could suppress candida albicans growth biofilm formation polymethyl methacrylate without impairing surface property systematic review effect ozone therapy root canal disinfection reported antimicrobial effect depended concentration ozone treatment period target microorganism evaluation term safe effective ozone concentration condition needed ozone ufbs created using device applied treatment limitation study first empyema usually treated using antibiotic drainage without lavage study antibiotic used aim evaluate bactericidal effect local treatment using ozone-ufbs second bactericidal effect intrathoracic lavage using ozone-ufbs empyema rat model evaluated aureus common cause empyema evaluated bactericidal effect ozone-ufbs several type bacteria vitro evaluation bacteria e.g. kind anaerobic bacteria multi-drug resistant bacteria required third find concentration-dependent bactericidal effect rat empyema model however may necessary determine optimal ozone concentration investigating relationship ozone concentration bactericidal effect finally bactericidal effect evaluated sacrificed rat study extent intrathoracic lavage using ozone-ufb solution clinically promotes empyema healing verified living animal model hope develop long-term empyema model combined systemic treatment evaluate additional effect intrathoracic lavage using ozone-ufb solution conclusion found ozone-ufbs solution bactericidal vitro rat model also found effective ozone concentration safe first paper verify efficacy safety ozone-ufbs body cavity study using living animal model determine therapeutic adverse effect ozone-ufb lavage required ozone-ufbs solution applied empyema human